Skip to content
Perrigo Company logo

Perrigo Company

PRGO

Perrigo Company plc is a leading global provider of over-the-counter (OTC) health and wellness solutions, specializing in the manufacture and distribution of self-care products.

Market cap
$1.4B-62.9%
Revenue$4.2B-3.6%
Net income-$1.8B-908%
Free cash flow$206.1M+35.9%
EPS (diluted)-$13.12-902%
Trailing twelve months · change vs. prior year

Earnings

Next report

Aug 5, 2026 (In 1 week)
Revenue estimate$1.0B
EPS estimate$0.39

Financials

Q1 2026

Income statement

See full
Revenue$969.2M-7.2%
Gross profit$325.5M-17.0%
Operating income-$372.3M-894%
Net income-$398.6M-6,128%
EPS (diluted)-$2.87-5,640%

Balance sheet

See full
Cash & equivalents$357.2M-12.9%
Total debt$3.8B-0.6%
Total equity$2.5B-42.7%
Total assets$8.0B-18.2%

Cash flow

See full
Operating cash flow-$113.6M-76.1%
CapEx$13.8M-45.9%
Free cash flow-$127.4M-41.6%

Valuation & ratios

Valuation

See full
Market cap$1.4B-62.9%
Enterprise value$4.87B-33.2%
P/S0.3×-0.6×

Profitability

See full
Gross margin34.2%-2.2pp
Operating margin-36.9%-41.8pp
Net margin-43.5%-48.6pp

Returns & leverage

See full
Return on equity-53%-57.7pp
Debt / equity1.5×+0.6×
Current ratio2.7×+0.4×

Segments

By product

See full
Upper Respiratory$197.4M-8.1%
Skin Health$151.9M
Healthy Lifestyle$142.7M-9.1%
Pain & Sleep$106.6M
Digestive Health$96.6M-14.4%

By segment

See full
Self Care$543.3M
Specialty Care$207.0M
Infant Formula$89.7M

Competitors

Profile

Perrigo Company plc is a leading global provider of over-the-counter (OTC) health and wellness solutions, specializing in the manufacture and distribution of self-care products. The company focuses on providing high-quality, affordable alternatives to national brands across various categories including consumer medicinals, nutrition, and personal care. Its value proposition centers on empowering consumers to manage their own health through accessible and regulated healthcare products.

Competitive position

A leading global provider of store-brand OTC products with a significant presence in the U.S. and European self-care markets.

GeographiesUnited States, Europe, Canada, Australia
Customer segmentsRetailers, Healthcare Providers, Government Agencies
Business modelManufacturing, B2B2C, Private Label
SuppliersActive Pharmaceutical Ingredient (API) suppliers, Raw material providers, Packaging manufacturers, Third-party contract manufacturers
CustomersRetail pharmacies, Mass merchandisers, Wholesale distributors, Medicare and Medicaid programs
CountryIreland
Listed1991
CEOAlbert A. Manzone
FilingsSEC EDGAR

Questions, answered.

What is Perrigo Company's market cap?
Perrigo Company (PRGO) has a market capitalization of $1.4B and trades on NYSE.
What is Perrigo Company's revenue and profitability?
Perrigo Company generated $4.2B in trailing twelve-month revenue with a net loss of $1.8B, representing a net margin of -43.5%. Gross margin stands at 34.2%, with free cash flow of $206.1M. These figures are based on the Q1 2026 filing.
Who are Perrigo Company's competitors?
Perrigo Company's key competitors include Abbott Laboratories, Johnson & Johnson, Prestige Consumer Healthcare Inc., and others. These companies compete in similar markets and product categories.
Where is Perrigo Company headquartered?
Perrigo Company is headquartered in Ireland. It has been publicly traded since 1991.